Gilead Sciences
GILD
1,496 hedge funds and large institutions have $63.4B invested in Gilead Sciences in 2018 Q4 according to their latest regulatory filings, with 153 funds opening new positions, 438 increasing their positions, 734 reducing their positions, and 163 closing their positions.
0.05% less ownership
Funds ownership: 79.31% → 79.26% (-0.05%)
6% less first-time investments, than exits
New positions opened: 153 | Existing positions closed: 163
2% less funds holding
Funds holding: 1,527 → 1,496 (-31)
12% less funds holding in top 10
Funds holding in top 10: 57 → 50 (-7)
20% less capital invested
Capital invested by funds: $79.3B → $63.4B (-$15.9B)
20% less call options, than puts
Call options by funds: $1.07B | Put options by funds: $1.34B
40% less repeat investments, than reductions
Existing positions increased: 438 | Existing positions reduced: 734
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI Investments Inc
Toronto,
Ontario, Canada
|
+$279M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$227M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$188M |
| 4 |
Millennium Management
New York
|
+$180M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$160M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$285M |
| 2 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$229M |
| 3 |
Bank of New York Mellon
New York
|
-$197M |
| 4 |
JP Morgan Chase
New York
|
-$157M |
| 5 |
N
Natixis
Paris,
France
|
-$152M |
GILD Hedge Fund Activity: Q4 2018 in Review
1,496 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q4 2018, worth a combined $63.4B — down 20% from $79.3B a quarter earlier.
Sellers outnumbered buyers: 163 funds closed out of GILD and 153 opened new positions — a net loss of 10 holders — while 734 trimmed existing stakes and 438 added.
The largest buyer was CI Investments Inc, adding an estimated $279M. The largest seller was Fidelity Investments, cutting an estimated $285M.
- 1,496 institutional investors held Gilead Sciences (GILD) as of Q4 2018, down from 1,527 in Q3 2018.
- Funds reported $63.4B of Gilead Sciences stock for Q4 2018, down 20% quarter-over-quarter.
- 153 funds opened new Gilead Sciences positions in Q4 2018 and 163 closed out, a net change of -10 holders.
- The largest Gilead Sciences buyer in Q4 2018 was CI Investments Inc, an estimated $279M added.
- The largest Gilead Sciences seller in Q4 2018 was Fidelity Investments, an estimated $285M sold.
Based on aggregated 13F filings for Q4 2018.